Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?

被引：14
|
作者：
Moschovi, Maria [1 ]
Adamaki, Maria [1 ]
Vlahopoulos, Spiros [1 ]
Rodriguez-Galindo, Carlos [2 ,3 ]
机构：
[1] Univ Athens Aghia Sofia Childrens Hosp, Dept Pediat 1, Pediat Hematol Oncol Unit, Athens 11527, Greece
[2] Dana Farber Boston Childrens Canc, Dept Pediat Hematol & Oncol, Boston, MA USA
[3] Blood Disorders Ctr, Boston, MA USA
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷 / 01期
关键词：
D O I：
10.1002/pbc.25173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] BRAF V600E Mutation and Papillary Thyroid Cancer Reply
    Cappola, Anne R.
    Mandel, Susan J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 535 - 536
  • [22] BRAF(V600E) mutation and the biology of papillary thyroid cancer
    Frasca, F.
    Nucera, C.
    Pellegriti, G.
    Gangemi, P.
    Attard, M.
    Stella, M.
    Loda, M.
    Vella, V.
    Giordano, C.
    Trimarchi, F.
    Mazzon, E.
    Belfiore, A.
    Vigneri, R.
    ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 191 - 205
  • [23] HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation
    Cao, X-X.
    Wu, Y.
    Liu, P.
    Ding, T.
    Ye, H.
    Cai, Z.
    Zhang, Y.
    Ma, J.
    Xu, Y.
    Fu, G.
    Hu, C.
    Hou, X.
    Wang, Q.
    Zhu, J.
    Li, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1599 - S1599
  • [24] Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation
    Charles, Julie
    Beani, Jean-Claude
    Fiandrino, Giacomo
    Busser, Benoit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (03) : E97 - E99
  • [25] Dramatic Efficacy of Dabrafenib in Langerhans Cell Histiocytosis Harboring the BRAF V600E Mutation: Two Cases Report
    Luo, Danqing
    Shi, Xiaodong
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S22 - S22
  • [26] Localized Langerhans cell, histiocytosis of the thymus with BRAF V600E mutation: a case report with immunohistochemical and genetic analyses
    Oishi, Naoki
    Kondo, Tetsuo
    Mochizuki, Kunio
    Inoue, Tomohiro
    Kasai, Kazunari
    Nakazawa, Tadao
    Mitsumori, Toru
    Katoh, Ryohei
    HUMAN PATHOLOGY, 2014, 45 (06) : 1302 - 1305
  • [27] BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis
    Bellinato, F.
    Maurelli, M.
    Colato, C.
    Balter, R.
    Girolomoni, G.
    Schena, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 933 - 934
  • [28] The Effect of BRAF V600E Mutation in the CD207+Cell of Langerhans Cell Histiocytosis on the Clinical Presentation and the Transcriptome
    Peters, Tricia
    Lim, Phaik H.
    Hicks, M. John
    McClain, Kenneth L.
    Allen, Carl E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A220 - A220
  • [29] BRAF V600E Mutation in Anaplastic Thyroid Carcinoma
    Walts, A. E.
    Pao, A.
    Bose, S.
    LABORATORY INVESTIGATION, 2014, 94 : 161A - 161A
  • [30] BRAF V600E Mutation in Anaplastic Thyroid Carcinoma
    Walts, A. E.
    Pao, A.
    Bose, S.
    MODERN PATHOLOGY, 2014, 27 : 161A - 161A
12345